Home LiteratureArticle Details
PMID: 8983270 Published · ppublish English Journal Article Review

Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?

European journal of cancer (Oxford, England : 1990) ·Vol. 32A ·No. 10 ·1996-09-00 ·Pages 1652-60

Bielack SS, Erttmann R, Kempf-Bielack B, Winkler K

Abstract

暂无摘要

MeSH Terms
Antibiotics, Antineoplastic/administration & dosage,adverse effects,therapeutic use Breast Neoplasms/drug therapy Doxorubicin/administration & dosage,adverse effects,therapeutic use Drug Administration Schedule Female Heart Failure/chemically induced Humans Lung Neoplasms/drug therapy Sarcoma/drug therapy
Chemicals
Antibiotics, Antineoplastic Doxorubicin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bielack S S
Abteilung für pädiatrische Hämatologie & Onkologie, Universitätskinderklinik Hamburg, Germany.
Erttmann R
Kempf-Bielack B
Winkler K
Article Info
Journal
European journal of cancer (Oxford, England : 1990)
Abbr.
Eur J Cancer
ISSN
0959-8049
DOI
10.1016/0959-8049(96)00177-3
Published
1996-09-00
Pages
1652-60
Language
English
Region
England
NLM ID
9005373
Subset
IM
External Links
PubMed source DOI: 10.1016/0959-8049(96)00177-3 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2